Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Arcturus Therapeutics Holdings Inc

ARCT
Current price
24.87 USD +1.33 USD (+5.65%)
Last closed 23.94 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 638 954 112 USD
Yield for 12 month +40.75 %
Week
Month
Year
ARCT
21.11.2021 - 28.11.2021

Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California. Address: 10628 Science Center Drive, San Diego, CA, United States, 92121

Analytics

WallStreet Target Price

43.07 USD

P/E ratio

6.359

Dividend Yield

Current Year

+205 755 000 USD

Last Year

+12 359 000 USD

Current Quarter

+43 376 000 USD

Last Quarter

+9 565 000 USD

Current Year

+205 755 000 USD

Last Year

+12 359 000 USD

Current Quarter

+43 376 000 USD

Last Quarter

+10 519 000 USD

Key Figures ARCT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 64 212 000 USD
Operating Margin TTM -42.79 %
PE Ratio 6.359
Return On Assets TTM 10.24 %
PEG Ratio
Return On Equity TTM 46.66 %
Wall Street Target Price 43.07 USD
Revenue TTM 296 236 992 USD
Book Value 10.48 USD
Revenue Per Share TTM 11.16 USD
Dividend Share
Quarterly Revenue Growth YOY 237.6 %
Dividend Yield
Gross Profit TTM 62 948 000 USD
Earnings Share 3.76 USD
Diluted Eps TTM 3.76 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin 33.53 %

Dividend Analytics ARCT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ARCT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:7
Payout Ratio
Last Split Date 16.11.2017
Dividend Date 16.11.2017

Stock Valuation ARCT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 6.359
Forward PE 2.8604
Enterprise Value Revenue 6.9215
Price Sales TTM 9.3831
Enterprise Value EBITDA -2.5022
Price Book MRQ 3.4283

Financials ARCT

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ARCT

For 52 weeks

14.21 USD 37.75 USD
50 Day MA 22.72 USD
Shares Short Prior Month 4 793 207
200 Day MA 25.39 USD
Short Ratio 17.15
Shares Short 4 987 470
Short Percent 25.07 %